iBio
IBIO
#9821
Rank
NZ$80.07 M
Marketcap
NZ$3.56
Share price
12.57%
Change (1 day)
-12.23%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): NZ-$2.63

According to iBio's latest financial reports the company's current EPS (TTM) is NZ-$2.66. In 2024 the company made an earnings per share (EPS) of NZ-$11.24 an increase over its 2023 EPS that were of NZ-$183.56.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$2.63-76.59%
2024NZ-$11.24-93.88%
2023NZ-$183.56-8.14%
2022NZ-$199.8392.67%
2021NZ-$103.72-80.33%
2020NZ-$527.22-35.11%
2019NZ-$812.44-38.96%
2018NZ-$1,331-6.1%
2017NZ-$1,41736.67%
2016NZ-$1,03733.33%
2015NZ-$777.8750%
2014NZ-$518.58-53.85%
2013NZ-$1,124-7.14%
2012NZ-$1,210-64.1%
2011NZ-$3,37177.27%
2010NZ-$1,901144.44%
2009NZ-$777.8712.93%
2008NZ-$688.8212.2%
2007NZ-$613.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Genocea Biosciences
GNCA
NZ-$0.90-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.44-191.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.05-777.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$13.78 417.53%๐Ÿ‡บ๐Ÿ‡ธ USA